DYN
Dyne Therapeutics Inc
15.40$
+1.6%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | -19.6% | +216.4% | +58.1% | -6.9% | -10.1% | +4.3% | +1.1% | +18.9% | +36.9% | -9.0% | -8.0% | |
| – | -23.1% | +277.3% | +62.3% | -7.1% | -10.5% | +4.6% | +1.2% | +15.5% | +39.7% | -9.4% | -8.1% | |
| – | -6.6% | +123.7% | +123.6% | -12.5% | -18.2% | +8.5% | +2.7% | +18.3% | +55.7% | -15.7% | -10.2% | |
| – | -22.0% | +268.4% | +71.7% | -7.1% | -11.2% | +5.5% | +0.9% | +15.8% | +40.2% | -12.5% | -7.6% | |
| – | +38.7% | -40.1% | +14.6% | +24.9% | -3.0% | -15.1% | +202.4% | +11.3% | +22.6% | +0.0% | +35.8% | |
| – | +72.1% | -56.2% | +33.0% | +45.4% | -2.3% | -19.8% | +22.4% | +44.3% | -15.4% | +1.2% | +52.3% | |
| – | +0.1% | +0.8% | +0.5% | +0.7% | +0.7% | +5.4% | -2.1% | +0.7% | -0.9% | +0.8% | +6.6% | |
| – | +545.5% | -68.5% | -73.8% | +225.9% | +6.6% | +7.0% | +99.7% | -13.9% | -33.0% | +33.4% | +12.7% | |
| – | – | – | – | – | – | – | – | +0.3% | +50.2% | +0.3% | +33.4% | |
| – | -40.0% | +423.7% | +62.2% | -9.0% | -10.7% | +6.2% | -14.6% | +21.1% | +40.5% | -11.0% | -18.8% | |
| – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +0.5% | +32.0% | +14.1% | +9.1% | +1.1% | +7.8% | +3.6% | +24.5% | -9.4% | +28.5% | +0.3% |
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.